东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300171 东富龙

交易中 03-19 09:42:51

{"stockData":{"symbol":"300171","market":"SZ","secType":"STK","nameCN":"东富龙","latestPrice":15.75,"timestamp":1773884571000,"preClose":16.15,"halted":0,"volume":1807805,"delay":0,"changeRate":-0.0248,"floatShares":563000000,"shares":766000000,"eps":0.2258,"marketStatus":"交易中","change":-0.4,"latestTime":"03-19 09:42:51","open":16,"high":16.03,"low":15.73,"amount":28698500,"amplitude":0.0186,"askPrice":15.77,"askSize":53,"bidPrice":15.76,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.2258,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1773891000000},"marketStatusCode":2,"adr":0,"adjPreClose":16.15,"symbolType":"stock","openAndCloseTimeList":[[1773883800000,1773891000000],[1773896400000,1773903600000]],"highLimit":17.77,"lowLimit":14.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":765828040,"isCdr":false,"pbRate":1.58,"roa":"--","peRate":69.751993,"roe":"1.68%","epsLYR":0.26,"committee":0.634109,"marketValue":12062000000,"turnoverRate":0.0032,"status":1,"floatMarketCap":8862000000},"requestUrl":"/m/hq/s/300171","defaultTab":"news","newsList":[{"id":"2619453630","title":"东富龙：公司作为一家制药整体解决方案的综合性制药装备服务商","url":"https://stock-news.laohu8.com/highlight/detail?id=2619453630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619453630?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:24","pubTimestamp":1773649472,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙03月16日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600021477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","300171","BK1574","BK0251","01477"],"gpt_icon":0},{"id":"2608870174","title":"东富龙（300171）披露2026年第一次临时股东会决议公告，2月03日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608870174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608870174?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:56","pubTimestamp":1770130574,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，东富龙报收于16.32元，较前一交易日上涨1.3%，最新总市值为124.98亿元。该股当日开盘16.22元，最高16.4元，最低16.17元，成交额达1.14亿元，换手率为1.24%。表决结果均获有效通过，律师见证本次会议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2608881747","title":"股市必读：东富龙（300171）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608881747","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608881747?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:59","pubTimestamp":1769979546,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，东富龙报收于16.46元，下跌1.38%，换手率1.69%，成交量9.51万手，成交额1.56亿元。交易信息汇总资金流向1月30日主力资金净流出67.61万元；游资资金净流出208.1万元；散户资金净流入275.71万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2607809415","title":"东富龙：致力于成为智慧药厂的交付者","url":"https://stock-news.laohu8.com/highlight/detail?id=2607809415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607809415?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:36","pubTimestamp":1769758574,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘，作为小小股东，请问一下印度这次病毒，公司在印度也是开拓了重要市场，请问在这个疫情中起到了什么作用？东富龙回复：您好！公司深耕生物医药行业三十余年，坚守“专业技术服务于生物医药”的使命，致力于成为智慧药厂的交付者。公司可以为全球制药企业提供设备+耗材+工程一体化的智能解决方案。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000020921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2606290433","title":"东富龙：公司管理层对公司战略方向与长期发展充满信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2606290433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606290433?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:12","pubTimestamp":1769415153,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：楚天科技的股价与市值就快超过公司了，业绩也增长强劲，公司的竞争对手如此之猛，管理层是否有危机感？东富龙回复：您好，感谢您的关注。我们始终密切关注行业市场动态与同行发展，以开放的心态学习行业优秀经验。公司专注自身发展、将持续提升核心竞争力作为首要任务。公司管理层对公司战略方向与长期发展充满信心，也将持续优化经营，努力以扎实的业绩回报投资者的信任。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2605470586","title":"东富龙：2025年度围绕“系统化、国际化、数智化”的发展战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2605470586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605470586?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:48","pubTimestamp":1769172488,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙01月22日在投资者关系平台上答复投资者关心的问题。2025年度，公司围绕“系统化、国际化、数智化”的发展战略，继续加强和补齐产品链条，提升产品核心竞争力和系统的联动、联调整体性功能，以更加优质、高效的产品服务我们的客户；加强海外营销市场布局，提升公司品牌知名度，推动实现国际化目标。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300039829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2604184937","title":"东富龙（300171）披露召开2026年第一次临时股东会通知，1月19日股价下跌2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604184937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604184937?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:28","pubTimestamp":1768814938,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，东富龙报收于17.25元，较前一交易日下跌2.87%，最新总市值为132.11亿元。该股当日开盘17.85元，最高17.89元，最低17.22元，成交额达4.59亿元，换手率为4.68%。近日，东富龙科技集团股份有限公司发布公告，宣布将于2026年2月3日召开2026年第一次临时股东会，会议由董事会召集，现场会议地点为上海市闵行区都会路139号五楼会议室。股权登记日为2026年1月28日。其中董事选举采用累积投票制，独立董事候选人需经深交所审核无异议后方可表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900023416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2604073185","title":"东富龙：提升产品智能化水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2604073185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604073185?lang=zh_cn&edition=full","pubTime":"2026-01-19 15:48","pubTimestamp":1768808893,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙01月19日在投资者关系平台上答复投资者关心的问题。公司积极开展研究工作，前瞻行业技术发展趋势及法规要求，加强研发人才的引进及研发能力的建设，不断提升产品的智能化水平，为制药企业提供智能制造整体解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900014795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2603980679","title":"股市必读：东富龙（300171）1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603980679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603980679?lang=zh_cn&edition=full","pubTime":"2026-01-16 02:25","pubTimestamp":1768501510,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，东富龙报收于18.17元，上涨1.06%，换手率2.73%，成交量15.36万手，成交额2.77亿元。董秘最新回复投资者： 公司属于AI医疗+智能制造吗？当日关注点来自交易信息汇总：1月15日主力资金净流出1104.67万元，散户资金净流入2114.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2603671070","title":"东富龙：提升产品智能化水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2603671070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603671070?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:36","pubTimestamp":1768462575,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：面对全球制药行业智能化转型趋势，公司如何通过 AI 技术实现从传统设备供应商向智慧药厂整体解决方案提供商的战略升级？东富龙回复：您好，公司积极开展研究工作，前瞻行业技术发展趋势及法规要求，不断提升产品的智能化水平，为制药企业提供智能制造整体解决方案。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500019917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2602939166","title":"股市必读：东富龙（300171）1月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602939166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602939166?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:16","pubTimestamp":1767892573,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，东富龙报收于17.03元，上涨2.1%，换手率2.32%，成交量13.07万手，成交额2.21亿元。董秘最新回复投资者： 公司持有上海诺诚电气多少股份董秘： 您好，截至目前，公司未持有上海诺诚电器股份，感谢您的关注！当日关注点来自交易信息汇总：1月8日主力资金净流入1775.8万元，显示主力对东富龙股票的积极介入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2601833831","title":"东富龙：坚守专业技术服务于生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2601833831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601833831?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:45","pubTimestamp":1767833113,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的企业文化是什么？可以详细的解说一下吗？谢谢东富龙回复：您好，公司及全体员工秉承“天道酬勤、诚信、敬业、创新、学习”的价值观，坚守专业技术服务于生物医药，致力于成为智慧药厂的交付者。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800006160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","161726","399441","BK0251"],"gpt_icon":0},{"id":"2601487839","title":"股市必读：东富龙（300171）1月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601487839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601487839?lang=zh_cn&edition=full","pubTime":"2026-01-06 02:11","pubTimestamp":1767636669,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，东富龙报收于16.64元，上涨5.99%，换手率2.74%，成交量15.44万手，成交额2.53亿元。董秘最新回复投资者： 公司参股了哪些生物医药公司？当日关注点来自交易信息汇总：1月5日主力资金净流入1659.23万元，显示主力对东富龙的积极布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600001115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2601001034","title":"东富龙：提升产品差异化竞争优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2601001034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601001034?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:54","pubTimestamp":1767603259,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：公司毛利净利率太差了，这样下去生存都困难！东富龙回复：您好，公司积极立足“提质增效”的主题，发挥产品创新的技术优势，提升公司产品结合前沿技术的能力，进一步打造产品的差异化竞争优势，做好为客户提供泛服务的能力，为赢取优质订单奠定扎实基础，努力提升公司的盈利能力。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500023189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2600067979","title":"每周股票复盘：东富龙（300171）开展2025年度持续督导培训","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067979","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067979?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:51","pubTimestamp":1767379868,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，东富龙报收于15.7元，较上周的15.94元下跌1.51%。本周，东富龙12月29日盘中最高价报16.07元。12月31日盘中最低价报15.6元。东富龙当前最新总市值120.24亿元，在医疗器械板块市值排名23/127，在两市A股市值排名1623/5181。本周关注点公司公告汇总：东富龙于2025年12月22日接受中信证券开展的持续督导培训。公司对本次培训积极配合，中信证券认为培训达到了预期效果，有助于提升公司规范运作水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2595795602","title":"东富龙（300171）披露2025年度持续督导培训情况，12月30日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595795602?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:55","pubTimestamp":1767088547,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，东富龙报收于15.78元，较前一交易日下跌0.94%，最新总市值为120.85亿元。该股当日开盘15.86元，最高15.97元，最低15.78元，成交额达7329.02万元，换手率为0.82%。公司近日发布公告称，中信证券股份有限公司于2025年12月22日在上海市闵行区都会路1509号对东富龙科技集团股份有限公司开展了2025年度持续督导培训。公司对本次培训积极配合，中信证券认为培训达到了预期效果，有助于提升公司规范运作水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000030748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2593049851","title":"东富龙：可提供药品制造核心装备整体解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2593049851","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593049851?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:25","pubTimestamp":1766478330,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司能为药企一个新建的厂房提供里面所有需要的装备设备吗？或只提供一部分？希望能认真回答我，谢谢！东富龙回复：您好，根据客户的需求，公司可以为客户定制化提供制药工艺、核心装备、系统工程整体解决方案，产品能涵盖药品制造过程中所需要的核心装备。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300023052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2593460028","title":"东富龙：募投项目实施进度有所放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=2593460028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593460028?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:21","pubTimestamp":1766478077,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙12月23日在投资者关系平台上答复投资者关心的问题。去年不是推迟一次了吗？行业下行周期还要多久才能到底？公司一直没有机构调研，到底怎么回事？公司将实时关注募投项目的实施进展，加强对项目实施过程中的动态控制，结合市场变化情况及公司经营发展需要，制定实施计划，合理统筹，有序推进募投项目后续建设。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300022578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2592160716","title":"东富龙（300171）披露部分募投项目延期公告，12月19日股价上涨0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592160716?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:18","pubTimestamp":1766153916,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，东富龙报收于15.37元，较前一交易日上涨0.92%，最新总市值为117.71亿元。该股当日开盘15.24元，最高15.46元，最低15.24元，成交额达8681.32万元，换手率为1.0%。东富龙近日发布公告称，公司于2025年12月19日召开董事会，审议通过关于部分募投项目延期的议案。其中，生物制药装备产业试制中心项目延期至2027年3月24日，江苏生物医药装备产业化基地项目延期至2027年1月10日，浙江东富龙生命科学产业化基地项目延期至2027年7月15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2591609329","title":"东富龙：子公司专注洁净药厂建设工程服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2591609329","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591609329?lang=zh_cn&edition=full","pubTime":"2025-12-16 15:21","pubTimestamp":1765869685,"startTime":"0","endTime":"0","summary":"东富龙回复：您好，公司全资子公司上海东富龙德惠空调设备有限公司、上海东富龙德惠净化空调工程安装有限公司秉承专业技术服务于生物医药的使命，专门从事洁净空调设备研发与生产、洁净药厂建设工程服务，专注于高端制药领域，如抗肿瘤原料药和抗肿瘤制剂、生物原液和生物制剂，服务了上百家国内外医药企业，积累了大量的项目经验，可以为新老客户提供更优质的服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600019726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773884575507,"stockEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.0341},{"period":"3month","weight":0.0604},{"period":"6month","weight":0.1421},{"period":"1year","weight":0.1845},{"period":"ytd","weight":0.0287}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.0481},{"period":"6month","weight":0.0636},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0237}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东富龙科技集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"31415人(较上一季度减少2.14%)","perCapita":"17910股","listingDate":"2011-02-01","address":"上海市闵行区都会路1509号4幢","registeredCapital":"76582万元","survey":"　　东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是生物工艺板块产品、制剂板块产品、工程整体解决方案、液态食品前处理线、食品冻干系统、液体灌装线及无菌灌装线。","listedPrice":86},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东富龙,300171,东富龙股票,东富龙股票老虎,东富龙股票老虎国际,东富龙行情,东富龙股票行情,东富龙股价,东富龙股市,东富龙股票价格,东富龙股票交易,东富龙股票购买,东富龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}